Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-06 10:30 am Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | INTRACOASTAL CAPITAL LLC | 891,401 9.99% | 891,401 (New Position) | View |
| 2023-02-08 06:07 am Unchanged | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | INTRACOASTAL CAPITAL LLC | 811,832 5.6% | 0 (Unchanged) | View |
| 2022-02-11 07:46 am Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | INTRACOASTAL CAPITAL LLC | 811,832 5.7% | 366,449 (+82.28%) | View |
| 2022-01-20 09:51 am Sale | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Empery Asset Management LP | 789,063 4.99% | -110,621 (-12.30%) | View |
| 2021-02-19 11:21 am Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Empery Asset Management LP | 899,684 6.76% | 899,684 (New Position) | View |
| 2021-02-16 10:03 am Sale | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments Inc. | 228,896 4% | -199,370 (-46.55%) | View |
| 2021-01-29 06:18 am Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | INTRACOASTAL CAPITAL LLC | 445,383 7.2% | 257,067 (+136.51%) | View |
| 2021-01-05 07:45 am Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | SABBY MANAGEMENT LLC | 288,452 11% | 102,747 (+55.33%) | View |
| 2020-04-09 10:13 am Sale | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments Inc. | 428,266 9.3% | -1,505,495 (-77.85%) | View |
| 2020-04-08 4:42 pm Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | ARMISTICE CAPITAL LLC | 240,592 4.99% | 240,592 (New Position) | View |
| 2020-02-14 2:49 pm Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | ARMISTICE CAPITAL LLC | 120,742 4.99% | 120,742 (New Position) | View |
| 2020-02-13 5:23 pm Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | INTRACOASTAL CAPITAL LLC | 188,316 9.99% | 188,316 (New Position) | View |
| 2020-02-11 1:04 pm Sale | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | SABBY MANAGEMENT LLC | 185,705 11% | -1,593,463 (-89.56%) | View |
| 2020-02-10 3:18 pm Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | CVI Investments Inc. | 1,933,761 4.9% | 1,933,761 (New Position) | View |
| 2020-01-22 11:30 am Purchase | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | SABBY MANAGEMENT LLC | 1,779,168 11% | 1,779,168 (New Position) | View |
| 2019-05-09 5:17 pm Purchase | 13D | PHIO PHARMACEUTICALS CORP COM PHIO | OPKO HEALTH INC. OPK | 66,857 0.3% | 66,857 (New Position) | View |